Clinical Trial Update: A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Takeda's TAK-186 (MVC-101) was studied in a Phase 1/2 trial for adults with advanced or metastatic cancers including squamous cell carcinoma of the head and nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• TAK-186 (MVC-101)

Snippet

Sponsor: Takeda | Conditions: Squamous Cell Cancer of Head and Neck (SCCHN), Non-small Cell Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: TERMINATED